1. Home
  2. UVV vs MLTX Comparison

UVV vs MLTX Comparison

Compare UVV & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$53.15

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$17.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
MLTX
Founded
1886
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UVV
MLTX
Price
$53.15
$17.13
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$29.73
AVG Volume (30 Days)
171.6K
1.1M
Earning Date
05-11-2026
06-01-2026
Dividend Yield
6.22%
N/A
EPS Growth
N/A
N/A
EPS
3.02
N/A
Revenue
$2,922,924,000.00
N/A
Revenue This Year
$0.67
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
$17.46
N/A
Revenue Growth
7.40
N/A
52 Week Low
$49.96
$5.95
52 Week High
$67.33
$62.75

Technical Indicators

Market Signals
Indicator
UVV
MLTX
Relative Strength Index (RSI) 47.11 48.54
Support Level $51.72 $17.00
Resistance Level $54.01 $19.15
Average True Range (ATR) 0.88 0.77
MACD -0.02 -0.18
Stochastic Oscillator 51.02 8.18

Price Performance

Historical Comparison
UVV
MLTX

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: